Venomyx Therapeutics: EpiPen for snakebites: the antivenom of tomorrow!

1

10x more effective than conventional antivenom.

2

Our antivenom saved 100% of mice from whole snake venom.

3

Our antivenom is made in bacteria instead of horses = cheaper and faster to produce.

4

Since it's made in bacteria, there are fewer risks of negative side effects in humans.

5

Vipax is stable at room temperatures for portability.

6

International patent for antivenom composition and methods.

7

$250K committed to $1.2M round so far.

Phil TanDirector of Scientific Research

15+ years of industry exp., Expert in developing better therapies for venoms & toxins. Part-time

Mads RiegelDirector of Business Development

Deep experience in startups, Expert in business development, company regulations, finance. Part-time

Founder & CEO

Extensive background in developing antibody drugs and bringing to market. MS Biomedical from UCSD.

Venomyx Therapeutics